Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 07/31/25
End: 12/31/31
Due: 12/31/32
Phase: N/A
Priority: Normal
Start: 08/18/20
End: 01/18/24
Due: 01/18/25
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| UI-Romi-02; Romiplostim Added to Standard of Care for Treatment Naive and Relapsed or Refractory Severe Aplastic Anemia | NCT07001254 | Anjali Sharathkumar | user2@example.com | None | 2025-07-31 | 2031-12-31 | 2032-12-31 | - | - | 2025-07-14 |
| TPO-Mimetic Use in Children for Hematopoietic Failure | NCT04478227 | Anjali Sharathkumar | user2@example.com | None | 2020-08-18 | 2024-01-18 | 2025-01-18 | - | - | 2025-07-14 |